Cargando…
Therapeutics Targeting p53-MDM2 Interaction to Induce Cancer Cell Death
Named as the guardian of the genome, p53 is a tumor suppressor that regulates cell function, often through many different mechanisms such as DNA repair, apoptosis, cell cycle arrest, senescence, metabolism, and autophagy. One of the genes that p53 activates is MDM2, which forms a negative feedback l...
Autores principales: | Koo, Nayeong, Sharma, Arun K., Narayan, Satya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103871/ https://www.ncbi.nlm.nih.gov/pubmed/35563397 http://dx.doi.org/10.3390/ijms23095005 |
Ejemplares similares
-
Targeting the p53–MDM2 interaction to treat cancer
por: Klein, C, et al.
Publicado: (2004) -
Energetic Landscape of MDM2-p53 Interactions by Computational Mutagenesis of the MDM2-p53 Interaction
por: Thayer, Kelly M., et al.
Publicado: (2016) -
The Dual Interactions of p53 with MDM2 and p300: Implications for the Design of MDM2 Inhibitors
por: Kannan, Srinivasaraghavan, et al.
Publicado: (2019) -
Targeting MDM4 as a Novel Therapeutic Approach in Prostate Cancer Independent of p53 Status
por: Mejía-Hernández, Javier Octavio, et al.
Publicado: (2022) -
Targeting p53–MDM2 interaction by small-molecule inhibitors: learning from MDM2 inhibitors in clinical trials
por: Zhu, Haohao, et al.
Publicado: (2022)